Anumana’s AI-enabled algorithm for the early detection of pulmonary hypertension (PH) has been cleared for use by the FDA.
FAYETTEVILLE, GA, UNITED STATES, April 2, 2026 /EINPresswire.com/ -- A new artificial intelligence method enables ...
Medical Device Network on MSN
FDA approves Anumana’s pulmonary hypertension algorithm
The algorithm integrates with EHR systems and ECG platforms, operating within the health system without external data ...
Anumana has been named to Fast Company’s prestigious 2026 Most Innovative Companies list in the Medical Devices category.
Proteogenomics explores how genetic information translates into protein expression and function, and the role of changes across DNA, RNA, and proteins in influencing disease development and ...
WEST LAFAYETTE, Ind. — Patent-pending imaging technologies created in Purdue University’s College of Engineering could be developed and commercialized for applications as diverse as medical imaging, ...
Existing loss of well control event indicators fall short of predicting events in an accurate and timely manner due to a lack ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results